Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:112-118

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bermejo, J.
Right arrow Articles by Delcán, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bermejo, J.
Right arrow Articles by Delcán, J. L.

(Circulation. 1998;98:112-118.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports

Mechanisms of Residual Lumen Stenosis After High-Pressure Stent Implantation

A Quantitative Coronary Angiography and Intravascular Ultrasound Study

Javier Bermejo, MD; Javier Botas, MD; Eulogio García, MD; Jaime Elízaga, MD; Julio Osende, MD; Javier Soriano, MD; Manuel Abeytua, MD; ; Juan Luis Delcán, MD

From the Department of Cardiology, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Spain.

Correspondence to Javier Botas, MD, Laboratorio de Hemodinámica, Departamento de Cardiología, Hospital General Universitario Gregorio Marañón, Dr Esquerdo 46, 28007 Madrid, Spain. E-mail javbotas{at}jet.es


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Intravascular ultrasound (IVUS) studies have demonstrated that stents are frequently suboptimally expanded despite the use of high pressures for deployment. The purpose of this study was to identify the mechanisms responsible for such residual lumen stenosis.

Methods and Results—Fifty-seven lesions from 50 patients treated with high-pressure (median±interquartile range, 14±2 atm) elective (44 de novo, 13 restenotic lesions) stenting were prospectively studied (29 Wiktor, Medtronic; 28 Palmaz-Schatz, Cordis Corp). Balloon subexpansion was calculated as the difference between maximal and minimal balloon cross-sectional areas at peak pressure measured by automatic edge detection; elastic recoil was calculated as the difference between minimal measured balloon size and IVUS-derived minimal lumen area within the stent. Angiographic residual diameter stenosis was 10±13% (reference diameter, 3.1±0.7 mm; balloon to artery ratio, 1.12±0.23) and IVUS-derived stent expansion was 80±28%. However, although balloon nominal size was 9.6±1.3 mm2 and maximal balloon size measured inside the coronary lumen was 12.5±3.2 mm2, final stent minimal lumen area was only 7.1±2.2 mm2. Balloon subexpansion of 4.0±1.8 mm2 (33%) and elastic recoil of 1.6±2.3 mm2 (20%) (both P<0.0001) were the two mechanisms responsible for residual luminal stenosis. Wiktor stent and peak inflation pressure correlated with balloon subexpansion, whereas Wiktor stent, de novo lesion, and minimal lumen area at baseline correlated with elastic recoil.

Conclusions—Despite high-pressure deployment, lumen dimensions after stenting are only 57% of maximal achievable. Inadequate balloon expansion and elastic recoil are responsible for residual lumen stenosis, suggesting that plaque characteristics and stent resistance deserve further investigation.


Key Words: stents • ultrasonics • revascularization • angioplasty • balloon


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The final dimension of the vessel lumen has been shown to be crucial both for reducing the risk of subacute occlusion1 2 and for improving long-term patency after intracoronary stent implantation.3 4 5 IVUS has demonstrated that despite excellent angiographic results, the stented lumen may still be further enlarged with additional balloon inflations at high pressures.1 6 This observation has led to the routine use of high inflation pressures for stent deployment, although long-term data regarding the benefit of this strategy are sparse.7 8 Moreover, recent IVUS studies9 10 have demonstrated that even when routinely implanted using high pressures, stents frequently remain suboptimally expanded. The present study was therefore designed to elucidate the mechanisms responsible for residual lumen stenosis after high-pressure coronary stenting.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Patients
From May 1994 to January 1997, patients were enrolled prospectively if (1) >=1 lesion was treated with a single elective Wiktor or Palmaz-Schatz stent implantation not preceded by any interventional device other than standard balloon predilation, and (2) IVUS examination was performed to assess the results of the procedure. Lesions with suboptimal angiographic or IVUS recordings were rejected. Thus, 57 coronary lesions (44 de novo; 13 restenotic; 29 Wiktor and 28 Palmaz-Schatz stents) from 50 patients (mean age, 59±14 years; 48 men, 2 women) constitute the basis of this study. At the time of intervention, 17 patients had stable angina, 29 had unstable angina, and 4 had postinfarction angina or inducible ischemia. The target vessel was the left anterior descending artery in 26 lesions, the right coronary artery in 20, the left circumflex in 10, and the left main in 1.

Written informed consent for intracoronary stenting and IVUS examination was obtained from all patients.

Procedure
All patients were premedicated with aspirin. Heparin was given as a bolus at the beginning of (10 000 to 15 000 IU IV) and during angioplasty (activated clotting time >300 seconds). After stenting, 46 patients received aspirin (150 to 360 mg/d) and ticlopidine (250 to 500 mg/d) and 4 received acenocoumarol.

Coronary angiography was performed through the femoral approach (8F catheters). Several angiographic projections of the segment of interest were obtained before intervention. The target lesion was predilated and stented by use of standard techniques. Balloon catheters (noncompliant and semicompliant) were selected among several manufacturers and sized according to angiographic vessel size. Balloons shorter than 20 mm were not used. Selection of type, length, and size of the stent was left to the individual operator, and the maximal inflation pressure (>=12 atm). If a residual stenosis persisted, additional balloon inflations were allowed, with larger balloons used if necessary. Balloons were filled with a 1:1 saline–contrast medium solution and were filmed during every inflation at maximum pressure. Special attention was given to purge the balloon and to allow sufficient time to achieve complete expansion during each inflation. Intracoronary nitroglycerin (200 µg) was administered before every set of angiograms and IVUS pullbacks.

Quantitative Coronary Angiography
Paired, identical, orthogonal views before and after stenting were chosen for QCA with the use of the Coronary Measurement System (versions 2.1 and 3.0, MEDIS Medical Imaging Systems).11 End-diastolic frames were selected for analysis, and the contrast-filled guiding catheters were used as the scaling device. A single catheter of each model used in the study was measured ex vivo filled with contrast on a 1-cm grid.12 Calibration factors were derived from these measurements for each catheter model and then used for in vivo analyses. MLDs and reference lumen diameters at baseline and after stenting were measured, as well as minimal, mean, and maximal balloon diameters at peak pressure. All balloon measurements were taken within balloon shoulders, and minimal balloon diameter was measured within stent boundaries. Diameters were averaged from paired angiograms when available; a circular shape was assumed when areas were calculated.

Interobserver and intraobserver (>3 months apart) variabilities (10 randomly selected angiograms) of minimal balloon diameters were ±0.19 mm (±6%) and ±0.17 mm (±4%), corresponding to ±0.9 mm2 (±13%) and ±1.1 mm2 (±9%) of balloon minimal CSA, respectively. Rintraclass values of interobserver and intraobserver reproducibilities were 0.72 and 0.95, respectively.

Intravascular Ultrasound
IVUS examination was performed using 30 MHz catheters (3.5F Sonicath or 2.9 to 3.2F CVIS, Boston Scientific Corp). The transducer was advanced distal to the target segment and then withdrawn manually or mechanically. A second pullback was then performed, and contrast was injected through the guiding catheter at the most relevant sites to improve lumen delineation. The complete study was recorded on 0.5-in Super VHS videotape for off-line analysis. Images of the MLA within the stent were digitized for measurement. Proximal and distal (only distal for ostial lesions) reference segments, within 10 mm of the stent borders, were also digitized. Care was taken to choose sites with the least disease within the reference segment. Lumen area was defined as the area within the leading edge of intimal and/or stent struts echoes. Analysis of IVUS recordings was performed without knowledge of the QCA results.

In 35 lesions (19 Wiktor, 16 Palmaz-Schatz), IVUS examination was also performed at baseline. From the image showing the smallest lumen, the following morphometric variables were measured13: MLA, plaque area, plaque eccentricity, arc of calcium (none, <90°, or >90°), and normalized plaque echogenicity (ratio between gray-scale values of plaque and adventitia).

Derived Parameters
Balloon nominal CSA was derived from the nominal diameter provided by the manufacturer. In vivo balloon subexpansion was calculated as maximal minus minimal QCA-measured balloon CSA. IVUS-derived elastic recoil was calculated as balloon minimal CSA minus IVUS MLA, whereas QCA-derived elastic recoil was computed as balloon minimal diameter minus MLD after stenting.14 Relative (%) values of subexpansion and recoil were obtained with absolute values normalized by the first term of their subtraction definition. Acute luminal gain was calculated as final MLA (derived from IVUS) minus minimal lumen CSA at baseline (derived from QCA). Maximal achievable gain was calculated as maximal measured balloon size in vivo minus minimal lumen CSA at baseline. Stent expansion was defined as the ratio between MLA within the stent and the average lumen CSA of proximal and distal references. Stent symmetry was defined as major/minor lumen diameters within the stent (measured by IVUS).

Statistical Analysis
Results are expressed as median±interquartile amplitude. Reproducibility and agreement were analyzed by Bland-Altman analysis15 and intraclass correlation coefficients (Rintraclass).16 Univariate analyses were performed with Spearman's correlation coefficient and paired t tests. Variable selection for the multiple linear regression models of balloon subexpansion and elastic recoil was performed by use of forward stepwise selection among the most relevant procedural and angiographic variables. The additive value of IVUS morphometric variables on these initial models was then screened by use of a global "chunk test" in the sample of 35 lesions with baseline IVUS examination; if this global test was significant, a second stepwise regression procedure was performed to select most relevant IVUS variables related to the effect. A 2-tailed P value <0.05 was considered significant.

IVUS and QCA Assessment of Final MLA
Agreement between IVUS and QCA in the assessment of MLA within the stent was -0.04±1.8 mm2 (Wiktor, -0.20±1.72 mm2; Palmaz-Schatz, 0.11±1.96 mm2; P=0.5). Rintraclass values also demonstrated poor agreement (0.42) between techniques (Wiktor, 0.36; Palmaz-Schatz, 0.48).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Procedural Results
Procedural, angiographic, and IVUS data at baseline and after stenting are shown in Table 1Down. No subacute occlusions occurred in the first 2 weeks after the procedure.


View this table:
[in this window]
[in a new window]
 
Table 1. Angiographic, IVUS, and Procedural Data at Baseline and After Stenting (n=57)

Balloon nominal CSA was 9.6±1.3 mm2 (Wiktor, 9.6±1.4; Palmaz-Schatz, 9.6±2.2 mm2; P=0.8), and maximal balloon dimension measured inside the coronary lumen was 12.5±3.2 mm2 (Wiktor, 13.0±3.5; Palmaz-Schatz, 11.4±3.1 mm2; P=0.08); however, final stent MLA was only 7.1±2.2 mm2, 74% and 57% of these values, respectively. At the end of the procedure, only 55% (6.1±3.0 mm2) of maximal achievable acute luminal gain (11.0±3.5 mm2) was obtained (P<0.0001; Figure 1Down).



View larger version (31K):
[in this window]
[in a new window]
 
Figure 1. Cumulative distribution functions of MLA at baseline (Pre MLA) and after stenting (Post MLA) and of balloon minimal and maximal CSAs. Top arrow indicates maximal achievable acute lumen gain according to size of balloon selected. However, due to balloon subexpansion (S) and elastic recoil (R), final achieved acute luminal gain (bottom arrow) is only 55% of maximal theoretical value.

Balloon Subexpansion
Measurements of the reference segment and balloon size are shown in Figure 2Down. Although in vivo measured mean balloon CSA was similar to nominal size, the size of the balloon was not uniform on its entire length. The balloon maximal CSA was substantially larger than its minimal CSA (12.5±3.2 versus 8.1±2.3 mm2; P<0.0001); therefore, values of absolute and relative balloon subexpansion were 4.0±1.8 mm2 (Wiktor, 4.4±1.8; Palmaz-Schatz, 3.5±1.7 mm2; P=0.1) and 33±12% (Wiktor, 34±10%; Palmaz-Schatz, 31±11%; P=0.4), respectively. Compared with nominal balloon size, minimal balloon CSA was 12% smaller (mean difference, 1.1 mm2; 95% CI, 0.7 to 1.4 mm2; P<0.001) and maximal CSA was 30% larger (mean difference, 3.1 mm2; 95% CI, 2.5 to 3.6 mm2; P<0.001), yielding a B/A ratio of 1.30±0.3 at the sites of maximal balloon CSA.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 2. Reference lumen and balloon dimensions. Interpolated angiographic vessel reference is in between the proximal and distal references obtained by IVUS. Balloon nominal CSA was not different from mean size measured by QCA. However, maximal and minimal values significantly differed from this nominal size, demonstrating supranominal balloon stretching at some regions of the treated segment and balloon subexpansion at others. *P<0.0001.

Elastic Recoil
As shown in Table 2Down, the final lumen within the stent was smaller than the minimum balloon size (P<0.0001 both for QCA-derived diameter and IVUS-derived CSA differences); thus, values of acute recoil were 0.4±0.5 mm (12±16%) and 1.6±2.3 mm2 (20±25%) as assessed by QCA-MLD and IVUS-MLA, respectively.


View this table:
[in this window]
[in a new window]
 
Table 2. Values of Final Lumen Dimensions After Stenting and Absolute and Relative Values of Acute Elastic Recoil as Assessed by QCA and IVUS

Factors Related to Balloon Subexpansion and Elastic Recoil
Increased absolute balloon subexpansion and absolute elastic recoil were found in Wiktor stents in multiple regression analysis (Table 3Down). As shown, peak balloon pressure directly correlated with balloon subexpansion, whereas elastic recoil was higher in de novo than in restenotic lesions. Baseline IVUS variables added no predictive value in the assessment of balloon subexpansion, whereas preintervention MLA inversely correlated with elastic recoil. When the multivariate models were rerun to assess factors related to relative values of subexpansion and recoil, the association between stent type and balloon subexpansion became nonsignificant (ß=-0.2, P=0.2); predictors of elastic recoil remained unchanged (stent type, ß=-0.2, P=0.06; type of lesion, ß=-0.3, P=0.03).


View this table:
[in this window]
[in a new window]
 
Table 3. Univariate and Multivariate Predictors of Balloon Subexpansion and Elastic Recoil


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
It is generally believed that supranominal inflation pressures should completely expand an angioplasty balloon catheter and that hoop resistance of stents should virtually avoid the vessel elastic recoil that follows balloon deflation.17 18 Accordingly, final vessel lumen size after stenting should closely match the size of the balloon used for deployment. However, the present study shows that lumen size after stenting reaches only 74% of the balloon nominal size and 57% of its inflated maximal in vivo size. The 10% angiographic residual diameter stenosis noted in the present study is lower than in previously reported randomized trials19 20 and is consistent with previous studies that used high-pressure inflations for stent deployment.1 Despite the routine use of slightly oversized balloons and high inflation pressures, balloon subexpansion and elastic recoil do occur and constitute 2 major sources of residual stenosis. The identification of these 2 mechanisms may help to develop strategies to improve stent deployment and, consequently, long-term results.

Balloon-Vessel Interaction During Stent Deployment
The dimensions of an inflated balloon in vivo, which have been extensively studied for standard balloon angioplasty, represent a complex interaction of balloon diameter, balloon material, inflation pressure, and vessel compliance.21 22 Of these factors, size selection seems crucial because randomized trials23 have demonstrated that procedural complications may increase when B/A ratios >1.1 are used. Similarly, several cases of coronary perforation during high-pressure stent implantation have been reported due to oversized balloons.1 18 24 Our study demonstrates that even adequately sized balloons achieve supranominal dimensions at certain points during high-pressure stent implantation, leading to potentially hazardous vessel stretch of the artery. It also demonstrates that supranominal pressures are frequently not enough to offset the high vessel impedance of the diseased artery.

An interference of stent architecture with balloon expansion constitutes another potential source of subexpansion. However, it has been reported that Palmaz-Schatz stents expand by almost 90% of peak size below 5 atm.25 Beyond this point, it is believed that no significant increase in pressure is needed in vitro to achieve full expansion of the balloon-stent assembly compared with the balloon alone. Because strain hardening of 316L stainless steel during stent expansion is negligible (Cordis Corp, unpublished data, 1997), stent size should parallel the size of the balloon without imposing relevant resistance. Whether stents behave similarly during in vivo high-pressure implantation remains to be ascertained.

Greater balloon subexpansion was observed for Wiktor than for Palmaz-Schatz stents in the present study. However, because maximal achieved balloon size was also larger for Wiktor stents, we believe such a difference in subexpansion could be due in part to greater compliance of the balloons used for Wiktor stent deployment. This hypothesis is supported by the observation of similar values of relative balloon subexpansion in both stent types, a parameter that corrects for differences in maximal balloon size within the coronary lumen.

Elastic Recoil During Stent Implantation
Acute elastic recoil designates the immediate reduction in vessel lumen that occurs after balloon deflation14 and accounts for a 50% loss in acute lumen gain during standard balloon angioplasty.26 27 The present study demonstrates that stents do not abolish recoil, because 20% of CSA was lost as a result of this phenomenon. This result is in agreement with recent observations in studies that used IVUS to assess final lumen CSA28 and with preliminary results from studies using an IVUS imaging wire.29 Angiographically measured recoil was 12%, which is consistent with previously reported values for Wiktor30 31 32 and Palmaz-Schatz stents.17 20 32 33 34

Due to their low yield point (close to 0.1 atm), balloon-expandable stents are plastically deformed during deployment and compression.35 36 However, greater force is needed in vivo to compress than to expand the stent due to the favorable effects of vessel impaction, friction, and longitudinal constraint.37 Pressures >0.8 and 0.5 atm are necessary to focally compress Wiktor and Palmaz-Schatz stents, respectively, in vitro.38 39 The observation of 1.6 mm2 (20%) of lumen recoil therefore demonstrates that elastic vessel hoop stress is above these values. Differences in vessel compliance probably account for the greater recoil observed in de novo than in restenotic lesions. Nevertheless, plaque protrusion through the stent struts also needs to be considered as a mechanism of lumen recoil, as demonstrated by IVUS40 and angioscopy examinations.41 Due to their smaller metallic surface, this mechanism may be responsible for the greater vessel recoil observed in coil stents in the present and in previous studies.42

Study Limitations
The overall reproducibility of QCA measurements of balloon minimal diameter was ±0.19 mm, slightly above the repeatability of QCA determination of lumen diameter.43 Furthermore, the calculation of balloon CSA from diameters implies the assumption of a circular shape of balloon cross sections. Although these are potential sources of error, derivation of balloon CSA from QCA diameters has been validated by densitometric analyses,14 even when highly radiopaque stents were attached to the inflated balloon.44 Future studies using smaller IVUS devices that are capable of imaging the artery through the inflated balloon should, however, improve in vivo measurements of expanded balloons.29 45

Lesions were predilated before stenting to allow the introduction of the device; it cannot be excluded that some noncontrolled factors, such as balloon type, size, or inflation pressure, might have influenced balloon subexpansion or elastic recoil.

Because baseline IVUS data were unavailable in a subset of patients, this study cannot correctly address how important plaque characteristics are as determinants of subexpansion and recoil; however, in the subset of lesions available, these factors seem less important than other procedural variables.

Clinical Implications
Serial IVUS studies have demonstrated that stent restenosis is related to neointimal hyperplasia because chronic vessel remodeling is negligible.46 Until adjuvant therapies aimed at reducing hyperplasia prove to be efficacious, obtaining the lowest residual lumen stenosis is the only available method to reduce restenosis of intracoronary stents and improve long-term outcome.3 5 The present study identifies that despite high-pressure deployment, only 55% of achievable acute lumen gain is finally obtained. Assessment of vessel size by IVUS examinations improves balloon-vessel matching and may help to reduce residual lumen stenosis after stenting, as demonstrated in standard PTCA procedures.47 Baseline IVUS examination may also enable identification of plaque characteristics related to subexpansion and recoil48 and hence, definition of tailored deployment techniques. Debulking before stenting modifies vessel impedance and seems to be another tempting strategy to increase luminal gain.48 49 50 Finally, the observation of an important loss of acute luminal gain due to immediate elastic recoil emphasizes the need for further research on stent design to maximize hoop strength and minimize tissue prolapse.


*    Selected Abbreviations and Acronyms
 
B/A = balloon/artery
CSA = cross-sectional area
IVUS = intravascular ultrasound
MLA = minimal lumen cross-sectional area
MLD = minimal lumen diameter
QCA = quantitative coronary angiography


*    Acknowledgments
 
We would like to thank the nurses and technicians of the catheterization lab and especially the excellent work of Alicia Barrio at the QCA laboratory. We are also indebted to Leonardo Fernández Troyano, MEng, PhD, for his assistance in the review of stent mechanical properties.


*    Footnotes
 
Presented in part at the 69th Scientific Sessions of the American Heart Association, New Orleans, La, November 10–13, 1996, and at the XVIIIth Congress of the European Society of Cardiology, Birmingham, United Kingdom, August 1996, and published in abstract form (Circulation. 1997;96[suppl I]I-223).

Received December 3, 1997; revision received February 27, 1998; accepted March 1, 1998.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676–1688.[Abstract/Free Full Text]

2. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol. 1996;27:494–503.[Abstract]

3. Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Wong SC, Leon MB. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995;26:720–724.[Abstract]

4. Kuntz RE, Safian RD, Carrozza JP, Fischman DL, Mansour M, Baim DS. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation. 1992;86:1827–1835.[Abstract/Free Full Text]

5. Ikari Y, Hara K, Tamura T, Saeki F, Yamaguchi T. Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantation. Am J Cardiol. 1995;76:117–120.[Medline] [Order article via Infotrieve]

6. Görge G, Haude M, Ge J, Voegele E, Gerber T, Rupprecht HJ, Meyer J, Erbel R. Intravascular ultrasound after low and high inflation pressure coronary artery stent implantation. J Am Coll Cardiol. 1995;26:725–730.[Abstract]

7. Nakamura S, Hall P, Gaglione A, Tiecco F, Di Maggio M, Maiello L, Martini G, Colombo A. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol. 1997;29:21–27.[Abstract]

8. Moussa I, Di Mario C, Di Francesco L, Reimers B, Blengino S, Colombo A. Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol. 1996;78:13–17.[Medline] [Order article via Infotrieve]

9. Botas J, Elízaga J, García E, Bermejo J, Soriano J, Abeytua M, Velasquez E, Fernández A, Delcán JL. IVUS assessment of high pressure stent implantation. J Am Coll Cardiol. 1996;27(suppl A):199A. Abstract.

10. Núñez BD, Holmes DR, Lerman A, Berger PB, Garratt KN, Higano ST. Detailed intravascular ultrasound analysis after routine high pressure assisted intracoronary stent implantation. J Am Coll Cardiol. 1996;27(suppl A):199A. Abstract.

11. Hauslelter J, Nolte CWT, Jost S, Wiese B, Sturm M, Lichtlen PR. Comparison of different quantitative coronary analysis systems: ARTREK, CAAS and CMS. Cathet Cardiovasc Diagn. 1996;37:14–22.[Medline] [Order article via Infotrieve]

12. Leung WH, Demopulos PA, Alderman AG, Sanders W, Stadius ML. Evaluation of catheters and metallic catheter markers as calibration standard for measurement of coronary dimension. Cathet Cardiovasc Diagn. 1990;21:148–153.[Medline] [Order article via Infotrieve]

13. Baptista J, di Mario C, Ozaki Y, Escaned J, Gil R, de Feyter P, Roelandt JR, Serruys PW. Impact of plaque morphology and composition on the mechanisms of lumen enlargement using intracoronary ultrasound and quantitative angiography after balloon angioplasty. Am J Cardiol. 1996;77:115–121.[Medline] [Order article via Infotrieve]

14. Hermans WR, Rensing BJ, Strauss BH, Serruys PW. Methodological problems related to the quantitative assessment of stretch, elastic recoil, and balloon-artery ratio. Cathet Cardiovasc Diagn. 1992;25:174–185.[Medline] [Order article via Infotrieve]

15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;8:307–310.

16. Tammemagi MC, Frank JW, Leblanc M, Artsob H, Streiner DL. Methodological issues in assessing reproducibility: a comparative study of various indices of reproducibility applied to repeat ELISA serologic tests for Lyme disease. J Clin Epidemiol. 1995;48:1123–1132.[Medline] [Order article via Infotrieve]

17. Haude M, Erbel R, Issa H, Meyer J. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents. J Am Coll Cardiol. 1993;21:26–34.[Abstract]

18. Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, Finci L, Tobis JM. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89:2026–2034.[Free Full Text]

19. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489–495.[Abstract/Free Full Text]

20. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldber S. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496–501.[Abstract/Free Full Text]

21. Hjemdahl-Monsen CE, Ambrose JA, Borrico S, Cohen M, Sherman W, Alexopoulos D, Gorlin R, Fuster V. Angiographic patterns of balloon inflation during percutaneous transluminal coronary angioplasty: role of pressure-diameter curves in studying distensibility and elasticity of the stenotic lesion and the mechanism of dilation. J Am Coll Cardiol. 1990;16:569–575.[Abstract]

22. Chenu P, Zakhia R, Marchandise B, Jamart J, Michel X, Schroeder E. Resistance of the atherosclerotic plaque during coronary angioplasty: a multivariate analysis of clinical and angiographic variables. Cathet Cardiovasc Diagn. 1993;29:203–209.[Medline] [Order article via Infotrieve]

23. Roubin GS, Douglas JS Jr, King SB, Lin SF, Hutchison N, Thomas RG, Gruentzig A. Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty: a prospective randomized study. Circulation. 1988;78:557–565.[Abstract/Free Full Text]

24. Alfonso F, Goicolea J, Hernandez R, Fernandez-Ortiz A, Segovia J, Banuelos C, Aragoncillo P, Phillips P, Macaya C. Arterial perforation during optimization of coronary stents using high-pressure balloon inflations. Am J Cardiol. 1996;78:1169–1172.[Medline] [Order article via Infotrieve]

25. Palmaz JC, Kopp DT, Hayashi H, Schatz RA, Hunter G, Tio FO, Garcia O, Alvarado R, Rees C, Thomas SC. Normal and stenotic renal arteries: experimental balloon-expandable intraluminal stenting. Radiology. 1987;164:705–708.[Abstract/Free Full Text]

26. Rozenman Y, Gilon D, Welber S, Sapoznikov D, Gotsman MS. Clinical and angiographic predictors of immediate recoil after successful coronary angioplasty and relation to late restenosis. Am J Cardiol. 1993;72:1020–1025.[Medline] [Order article via Infotrieve]

27. Rodríguez AE, Palacios IF, Fernández MA, Larribau M, Giraudo M, Ambrose JA. Time course and mechanism of early luminal diameter loss after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1995;76:1131–1134.[Medline] [Order article via Infotrieve]

28. Itoh A, Hall P, Maiello L, Blengino S, Ferraro M, Martini G, Finci L, Colombo A. Acute recoil of Palmaz-Schatz stent: a rare cause of suboptimal stent implantation: report of two cases with intravascular ultrasound findings. Cathet Cardiovasc Diagn. 1996;37:334–338.[Medline] [Order article via Infotrieve]

29. Maiello L, Itoh A, Colombo A. Valutazione del "recoil" acuto dello stent di Palmaz-Schatz mediante ecografia: descrizione di un caso. Cardiologia. 1996;41:559–562.[Medline] [Order article via Infotrieve]

30. Serruys PW, de Jaegere P, Bertrand M, Kober G, Marquis JF, Piessens J, Uebis R, Valeix B, Wiegand V. Morphologic change in coronary artery stenosis with the Medtronic Wiktor stent: initial results from the core laboratory for quantitative angiography. Cathet Cardiovasc Diagn. 1991;24:237–245.[Medline] [Order article via Infotrieve]

31. de Jaegere P, Serruys PW, van Es GA, Bertrand M, Wiegand V, Marquis JF, Vrolicx M, Piessens J, Valeix B, Kober G, Rutsch W, Uebis R. Recoil following Wiktor stent implantation for restenotic lesions of coronary arteries. Cathet Cardiovasc Diagn. 1994;32:147–156.[Medline] [Order article via Infotrieve]

32. White CJ. Stent recoil: comparison of the Wiktor-GX coil and the Palmaz-Schatz tubular coronary stent. Cathet Cardiovasc Diagn. 1997;41:1–3.[Medline] [Order article via Infotrieve]

33. Rechavia E, Litvack F, Macko G, Eigler N. Influence of expandable balloon diameter on Palmaz-Schatz stent recoil. Cathet Cardiovasc Diagn. 1995;36:11–16.[Medline] [Order article via Infotrieve]

34. Painter JA, Mintz GS, Wong SC, Popma JJ, Pichard AD, Kent KM, Satler LF, Leon MB. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol. 1995;75:398–400.[Medline] [Order article via Infotrieve]

35. Berry JL, Newman VS, Ferrario CM, Routh WD, Dean RH. A method to evaluate the elastic behavior of vascular stents. J Vasc Interv Radiol. 1996;7:381–385.[Medline] [Order article via Infotrieve]

36. Lossef SV, Lutz RJ, Mundorf J, Barth KH. Comparison of mechanical deformation properties of metallic stents with use of stress-strain analysis. J Vasc Interv Radiol. 1994;5:341–349.[Medline] [Order article via Infotrieve]

37. Flueckiger F, Sternthal H, Klein GE, Aschauer M, Szolar D, Kleinhappl G. Strength, elasticity and plasticity of expandable metal stents: in vitro studies with three types of stress. J Vasc Interv Radiol. 1994;5:745–750.[Medline] [Order article via Infotrieve]

38. White CJ, van der Krieken T. The Wiktor stent. In: Sigwart U, ed. Endoluminal Stenting. London, England: WB Saunders; 1996:185–189.

39. Sklar M, Schatz RA. The Palmaz-Schatz stent. In: Sigwart U, ed. Endoluminal Stenting. London, England: WB Saunders; 1996:160–172.

40. Ponde CK, Aroney CN, McEniery PT, Bett JH. Plaque prolapse between the struts of the intracoronary Palmaz-Schatz stent: report of two cases with a novel treatment of this unusual problem. Cathet Cardiovasc Diagn. 1997;40:353–357.[Medline] [Order article via Infotrieve]

41. Strumpf RK, Heuser RR, Eagan JT. Angioscopy: a valuable tool in the deployment and evaluation of intracoronary stents. Am Heart J. 1993;126:1204–1210.[Medline] [Order article via Infotrieve]

42. Werner GS, Schünemann S, Ferrari M, Figulla HR, Kreuzer H. Comparison of slotted-tube and coil stents after high-pressure stent deployment by intravascular ultrasound. J Am Coll Cardiol. 1997;27(suppl A):275A. Abstract.

43. Reiber JH, van der Zwet PM, Koning G, von Land CD, van Meurs B, Gerbrands JJ, Buis B, van Voorthuisen AE. Accuracy and precision of quantitative digital coronary arteriography: observer-, short-, and medium-term variabilities. Cathet Cardiovasc Diagn. 1993;28:187–198.[Medline] [Order article via Infotrieve]

44. Strauss BH, Rensing BJ, den Boer A, van der Giessen WJ, Reiber JH, Serruys PW. Do stents interfere with the densitometric assessment of a coronary artery lesion? Cathet Cardiovasc Diagn. 1991;24:259–264.[Medline] [Order article via Infotrieve]

45. Isner JM, Rosenfield K, Losordo DW, Rose L, Langevin RE, Razvi S, Kosowsky BD. Combination balloon-ultrasound imaging catheter for percutaneous transluminal angioplasty: validation of imaging, analysis of recoil and identification of plaque fracture. Circulation. 1991;84:739–754.[Abstract/Free Full Text]

46. Hoffman R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94:1247–1254.[Abstract/Free Full Text]

47. Stone GW, Hodgson JM, St Goar FG, Frey A, Mudra H, Sheehan H, Linnemeier TJ. Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing: the CLOUT Pilot Trial. Circulation. 1997;95:2044–2052.[Abstract/Free Full Text]

48. Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Wong C, Brahimi A, Bucher T, Leon MB. Safety and efficacy of elective stent implantation following rotational atherectomy in large calcified coronary arteries. Cathet Cardiovasc Diagn. 1996;(suppl 3):50–54.

49. Moussa I, Di Mario C, Moses J, Reimers B, Di Francesco L, Martini G, Tobis J, Colombo A. Coronary stenting after rotational atherectomy in calcified and complex lesions: angiographic and clinical follow-up results. Circulation. 1997;96:128–136.[Abstract/Free Full Text]

50. Moussa I, Moses JW, Strain JE, Kreps EM, Peters MJ, Colombo A. Angiographic and clinical outcome of patients undergoing "Stenting After Optimal Lesion Debulking": the "SOLD" pilot study. Circulation. 1997;96(suppl I):I-81. Abstract.




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
H. Samady, M. McDaniel, E. Veledar, B. De Bruyne, N. H. Pijls, W. F. Fearon, and V. Vaccarino
Baseline Fractional Flow Reserve and Stent Diameter Predict Optimal Post-Stent Fractional Flow Reserve and Major Adverse Cardiac Events After Bare-Metal Stent Deployment
J. Am. Coll. Cardiol. Intv., April 1, 2009; 2(4): 357 - 363.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo
Drug-eluting stenting the case for post-dilation.
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 22 - 31.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E. De Benedetti and P. Urban
Coronary stenting: why size matters
Heart, December 1, 2007; 93(12): 1500 - 1501.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S. Aziz, J. L Morris, R. A Perry, and R. H Stables
Stent expansion: a combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size
Heart, December 1, 2007; 93(12): 1562 - 1566.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Alfonso, A Suarez, D J Angiolillo, M Sabate, J Escaned, R Moreno, R Hernandez, C Banuelos, and C Macaya
Findings of intravascular ultrasound during acute stent thrombosis
Heart, December 1, 2004; 90(12): 1455 - 1459.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al.
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Spanos, G. Stankovic, J. Tobis, and A. Colombo
The challenge of in-stent restenosis: insights from intravascular ultrasound
Eur. Heart J., January 2, 2003; 24(2): 138 - 150.
[Full Text] [PDF]


Home page
CirculationHome page
N. H.J. Pijls, V. Klauss, U. Siebert, E. Powers, K. Takazawa, W. F. Fearon, J. Escaned, Y. Tsurumi, T. Akasaka, H. Samady, et al.
Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up: A Multicenter Registry
Circulation, June 25, 2002; 105(25): 2950 - 2954.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Takano, L. A. Yeatman, J. R. Higgins, J. W. Currier, E. Ascencio, K. A. Kopelson, and J. M. Tobis
Optimizing stent expansion with new stent delivery systems
J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1622 - 1627.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. J. de Feyter, P. Kay, C. Disco, and P. W. Serruys
Reference Chart Derived From Post-Stent-Implantation Intravascular Ultrasound Predictors of 6-Month Expected Restenosis on Quantitative Coronary Angiography
Circulation, October 26, 1999; 100(17): 1777 - 1783.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Dirschinger, A. Kastrati, F.-J. Neumann, P. Boekstegers, S. Elezi, J. Mehilli, H. Schuhlen, J. Pache, E. Alt, R. Blasini, et al.
Influence of Balloon Pressure During Stent Placement in Native Coronary Arteries on Early and Late Angiographic and Clinical Outcome : A Randomized Evaluation of High-Pressure Inflation
Circulation, August 31, 1999; 100(9): 918 - 923.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. Carrozza Jr, S. E. Hosley, D. J. C. MD, and D. S. Baim
In Vivo Assessment of Stent Expansion and Recoil in Normal Porcine Coronary Arteries : Differential Outcome by Stent Design
Circulation, August 17, 1999; 100(7): 756 - 760.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. D. Peterson, P. A. Cowper, E. R. DeLong, J. P. Zidar, R. S. Stack, and D. B. Mark
Acute and long-term cost implications of coronary stenting
J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1610 - 1618.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bermejo, J.
Right arrow Articles by Delcán, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bermejo, J.
Right arrow Articles by Delcán, J. L.